Larvol Delta - AntiOX40-Antibody-in-Head-and-Neck-Cancer-Patients

MEDI6469 - AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT02274155

Jul 15, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next